CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries

3.5.2. Restraints

3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices

3.5.3. Opportunities

3.5.3.1. Huge market opportunities in the developing countries

CHAPTER 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RECONSTRUCTIVE JOINT REPLACEMENTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants

4.2.4.1. Market size and forecast

4.2.5. Hip replacement implants

4.2.5.1. Market size and forecast

4.2.6. Extremities

4.2.6.1. Market size and forecast
4.2.6.2. Upper Extremity Reconstruction

4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder Reconstruction

4.2.6.2.2.1. Market size and forecast

4.2.6.2.3. Elbow Reconstruction

4.2.6.2.3.1. Market size and forecast

4.2.6.2.4. Hand & Wrist

4.2.6.2.4.1. Market size and forecast

4.2.6.3. Lower Extremity Reconstruction

4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot Reconstruction

4.2.6.3.2.1. Market size and forecast

4.2.6.3.3. Ankle Reconstruction

4.2.6.3.3.1. Market size and forecast

4.3. SPINAL IMPLANTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal Fusion Devices

4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar Devices

4.3.4.2.1. Market size and forecast

4.3.4.3. Cervical Fixation Devices

4.3.4.3.1. Market size and forecast

4.3.4.4. Interbody Fusion Devices

4.3.4.4.1. Market size and forecast

4.3.5. Motion Preservation Devices

4.3.5.1. Market size and forecast
4.3.5.2. Dynamic Stabilization Devices

4.3.5.2.1. Market size and forecast

4.3.5.3. Artificial Discs

4.3.5.3.1. Market size and forecast

4.3.5.4. Annulus Repair Devices

4.3.5.4.1. Market size and forecast

4.3.5.5. Nuclear Disc Prostheses

4.3.5.5.1. Market size and forecast

4.3.6. Vertebral Compression Fracture (VCF) Treatment Devices

4.3.6.1. Market size and forecast
4.3.6.2. Balloon Kyphoplasty Devices

4.3.6.2.1. Market size and forecast

4.3.6.3. Vertebroplasty Devices

4.3.6.3.1. Market size and forecast

4.3.7. Invasive Spinal Bone Stimulators

4.3.7.1. Market size and forecast

4.4. DENTAL IMPLANTS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root Form Dental Implants

4.4.4.1. Market size and forecast

4.4.5. Plate Form Dental Implants

4.4.5.1. Market size and forecast

4.5. ORTHOBIOLOGICS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts

4.5.4.1. Market size and forecast
4.5.4.2. Machined Allograft

4.5.4.2.1. Market size and forecast

4.5.4.3. Demineralized Bone Matrix (DBM)

4.5.4.3.1. Market size and forecast

4.5.5. Bone Graft Substitutes

4.5.5.1. Market size and forecast
4.5.5.2. Bone Morphogenic Proteins (BMP)

4.5.5.2.1. Market size and forecast

4.5.5.3. Synthetic Bone Grafts

4.5.5.3.1. Market size and forecast

4.5.6. Cell Based Matrices (CBM)

4.5.6.1. Market size and forecast

4.6. TRAUMA & CRANIOMAXILLOFACIAL

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw

4.6.4.1. Market size and forecast

4.6.5. Plates

4.6.5.1. Market size and forecast

4.6.6. Staples

4.6.6.1. Market size and forecast

4.6.7. Others

4.6.7.1. Market size and forecast

CHAPTER 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CERAMICS BIOMATERIALS

5.2.1. Market size and forecast

5.3. METALLIC BIOMATERIALS

5.3.1. Market size and forecast

5.4. POLYMERIC BIOMATERIALS

5.4.1. Market size and forecast

5.5. NATURAL BIOMATERIALS

5.5.1. Market size and forecast

CHAPTER 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial

6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.1. Key growth factors and opportunities
6.3.2. Market size and forecast by country
6.3.3. Market size and forecast by Product
6.3.4. Market size and forecast by Biomaterial

6.3.4.1. Germany market size and forecast
6.3.4.2. France market size and forecast
6.3.4.3. UK market size and forecast
6.3.4.4. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial

6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial

6.5.5.1. Latin America market size and forecast
6.5.5.2. South Africa market size and forecast
6.5.5.3. Middle East market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. BIOTEK INSTRUMENTS, INC.

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves and developments

7.2. CONMED CORPORATION

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments

7.3. JOHNSON & JOHNSON (DEPUY SYNTHES)

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments

7.4. MEDTRONIC PLC

7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments

7.5. SMITH AND NEPHEW PLC

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments

7.6. STRYKER CORPORATION

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments

7.7. THE ORTHOPAEDIC IMPLANT COMPANY

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves and developments

7.8. WRIGHT MEDICAL GROUP N.V.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves and developments

7.9. ZIMMER BIOMET HOLDINGS, INC.

7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments

7.10. AESCULAP IMPLANT SYSTEMS

7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves and developments